A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients)
Abstract Objective Cenobamate (CNB), a recently approved antiseizure medication by the European Medicines Agency (EMA), serves as an adjunctive therapy for focal‐onset seizures in adult patients unresponsive to at least two other treatments. Administered in polytherapy, CNB can potentially interact...
Saved in:
| Main Authors: | Federica Pigliasco, Alessia Cafaro, Sebastiano Barco, Margherita Biondi, Manuela Stella, Francesca Mattioli, Antonella Riva, Ugo deGrazia, Linda Molteni, Elisa Micalizzi, Flavio Villani, Pasquale Striano, Roberto Bandettini, Giuliana Cangemi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Epilepsia Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/epi4.12927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of add‐on Cenobamate treatment in refractory epilepsy due to Rasmussen's encephalitis
by: Andres Schulze‐Bonhage, et al.
Published: (2024-12-01) -
Inhibitory Effects of Cenobamate on Multiple Human Cardiac Ion Channels and Possible Arrhythmogenic Consequences
by: Andreea Larisa Mateias, et al.
Published: (2024-12-01) -
LC-MS-Based Global Metabolic Profiles of Alternative Blood Specimens Collected by Microsampling
by: Marlene N. Thaitumu, et al.
Published: (2025-01-01) -
Volumetric Absorptive Microsampling in Toxicology
by: Bruno Pires, et al.
Published: (2024-12-01) -
Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches
by: Stéphane Auvin, et al.
Published: (2025-02-01)